Dr Michael Veness

Clinical Associate Professor
Medicine, Westmead Clinical School

Telephone 9845 5200 ext 57125
Fax 98915814

Map

Biographical details

Dr Michael Veness has been a full time staff specialist in Radiation Oncology at the Westmead and Nepean hospitals, Sydney, since 1998. His clinical practice predominantly involves managing patients with mucosal and cutaneous malignancies of the head and neck.He maintains a large prospective database of patients with advanced skin cancers and collaborates with other researchers using this data. Michael has a longstanding clinical research focus on the important and beneficial role of radiotherapy in treating patients with non-melanoma skin cancer and, in particular, patients diagnosed with Merkel cell carcinoma (primary cutaneous neuroendocrine malignancy) and high-risk cutaneous squamous cell carcinomas (especially those with metastatic nodes). In addition to a Masters degree in Clinical Epidemiology he has been awarded MDs by published work from both the University of NSW and University of Sydney and has published widely, both locally and internationally, over 100 peer reviewed publications and book chapters on various skin cancer related topics and is a clinical associate professor with the Sydney Medical School, University of Sydney. Michael believes strongly in educating and informing clinicians managing patients with skin cancer of the often underappreciated benefits, which in some cases can be lifesaving, to utilizing radiotherapy, be that, definitive (i.e. radical), adjuvant (i.e. post op) or palliative radiotherapy.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Veness, M., Morgan, G., Howle, J. (2012). Recurrent Melanotic and Nonmelanotic Skin Cancer. In H. Mehanna & K. K. Ang (Eds.), Head and Neck Cancer Recurrence: Evidence-based, Multidisciplinary Management, (pp. 229-244). Stuttgart: Georg Thieme Verlag.
  • Palme, C., Smith, M., Veness, M. (2011). Epidemiology, Staging and Prognosis of Nonmelanoma Skin Cancer. In Randal S. Weber, Brian A. Moore (Eds.), Cutaneous Malignancy of the Head and Neck: A Multidisciplinary Approach, (pp. 101-118). San Diego, CA, USA: Plural Publishing.
  • Veness, M. (2008). Radiation Therapy in Organ Transplant Recipients. In Otley C; Stasko T (Eds.), Skin Disease in Organ Transplantation, (pp. 254-261). New York, NY: Cambridge University Press.
  • Veness, M., Richards, S. (2008). Radiotherapy. In Jean L Bolognia, Joseph L Jorizzo, Ronald P Rapini (Eds.), Dermatology (2nd Edition), (pp. 2127-2138). United States: Mosby.

Journals

  • Howle, J., Veness, M. (2014). Outcome of Patients with Microscopic and Macroscopic Metastatic Nodal Merkel Cell Carcinoma: An Australian Experience. Dermatologic Surgery, 40(1), 46-51. [More Information]
  • McLean, T., Brunner, M., Ebrahimi, A., Gao, K., Ch’ng, S., Veness, M., Clark, J. (2013). Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors. Head and Neck, 35(8), 1144-1148. [More Information]
  • Brunner, M., Veness, M., Ch'ng, S., Elliott, M., Clark, J. (2013). Distant metastases from cutaneous squamous cell carcinoma - analysis of AJCC stage IV. Head and Neck, 35(1), 72-75. [More Information]
  • Najim, M., Cross, S., Gebski, V., Palme, C., Morgan, G., Veness, M. (2013). Early-stage squamous cell carcinoma of the lip: The Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection. Head and Neck, 35(10), 1426-1430. [More Information]
  • Hong, A., Martin, A., Armstrong, B., Lee, C., Jones, D., Chatfield, M., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Veness, M., Veivers, D., Rose, B., et al (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24(1), 215-219. [More Information]
  • Wang, J., Palme, C., Wang, A., Morgan, G., Gebski, V., Veness, M. (2013). In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. The Journal of Laryngology and Otology, 127(Suppl. S1), S2-S7. [More Information]
  • Ebrahimi, A., Clark, J., Ahmadi, N., Palme, C., Morgan, G., Veness, M. (2013). Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases. Head and Neck, 35(8), 1138-1143. [More Information]
  • Wang, A., Palme, C., Wang, J., Morgan, G., Gebski, V., GILCHRIST, J., Veness, M. (2013). Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck. The Journal of Laryngology and Otology, 127(Suppl. S2), S39-S47. [More Information]
  • Ch'ng, S., Clark, J., Brunner, M., Palme, C., Morgan, G., Veness, M. (2013). Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head and Neck, 35(2), 190-194. [More Information]
  • Clark, J., Rumcheva, P., Veness, M. (2012). Analysis and Comparison of the 7th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System for Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Annals of Surgical Oncology, 19(13), 4252-4258. [More Information]
  • Howle, J., Hughes, T., Gebski, V., Veness, M. (2012). Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. Journal Of The American Academy Of Dermatology, 67(1), 33-40. [More Information]
  • Foote, M., Veness, M., Zarate, D., Poulsen, M. (2012). Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) disease. Journal Of The American Academy Of Dermatology, 67(3), 395-399. [More Information]
  • Ebrahimi, A., Clark, J., Lorincz, B., Milross, C., Veness, M. (2012). Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low-risk patient. Head and Neck, 34(3), 365-370. [More Information]
  • Wang, J., Palme, C., Morgan, G., Gebski, V., Wang, A., Veness, M. (2012). Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy. Head and Neck, 34(11), 1524-1528. [More Information]
  • Howle, J., Veness, M. (2012). Sentinel lymph node biopsy in patients with Merkel cell carcinoma: An emerging role and the Westmead hospital experience. The Australasian Journal of Dermatology, 53(1), 26-31. [More Information]
  • Veness, M., Howle, J. (2011). Merkel cell carcinoma metastatic to the transverse colon: Disease free after six years - cure or just prolonged remission? Australasian Journal of Dermatology, 52(4), 295-297. [More Information]
  • Poulsen, M., Round, C., Keller, J., Tripcony, L., Veness, M. (2010). Factors Influencing Relapse-Free Survival in Merkel Cell Carcinoma of the Lower Limb - A Review of 60 Cases. International Journal of Radiation: Oncology - Biology - Physics, 76(2), 393-397. [More Information]
  • Goh, A., Howle, J., Hughes, M., Veness, M. (2010). Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes. Australasian Journal of Dermatology, 51(2), 113-117. [More Information]
  • Turner, S., Morgan, G., Palme, C., Veness, M. (2010). Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. Journal of Laryngology and Otology, 124(1), 26-31. [More Information]
  • Forest, V., Clark, J., Veness, M., Milross, C. (2010). N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer, 116(5), 1298-1304. [More Information]
  • Veness, M., Howle, J. (2010). Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases. Australasian Journal of Dermatology, 51(4), 274-278. [More Information]
  • Veness, M. (2010). Strategies to successfully publish your first manuscript. Journal of Medical Imaging and Radiation Oncology, 54(4), 395-400. [More Information]
  • Concannon, R., Larcos, G., Veness, M. (2010). The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia. Journal Of The American Academy Of Dermatology, 62(1), 76-84. [More Information]
  • Veness, M., Foote, M., Gebski, V., Poulsen, M. (2010). The Role of Radiotherapy Alone in Patients With Merkel Cell Carcinoma: Reporting the Australian Experience of 43 Patients. International Journal of Radiation: Oncology - Biology - Physics, 78(3), 703-709. [More Information]
  • Oddone, N., Morgan, G., Palme, C., Perera, L., Shannon, J., Wong, E., Gebski, V., Veness, M. (2009). Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer, 115(9), 1883-1891. [More Information]
  • Koh, C., Veness, M. (2009). Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature. Australasian Journal of Dermatology, 50(4), 249-256. [More Information]
  • Veness, M., Chong, L., Tiver, K., Gebski, V. (2008). Basal cell carcinoma of the nose: An Australian and New Zealand Radiation Oncology patterns-of practice study. Journal of Medical Imaging and Radiation Oncology, 52, 382-393. [More Information]
  • Veness, M., Palme, C., Morgan, G. (2008). Merkel cell carcinoma: a review of management. Current opinion in otolaryngology & head and neck surgery, 16(2), 170-174. [More Information]
  • Howle, J., Morgan, G., Palme, C., Kalnins, I., Veness, M. (2008). Metastatic cutaneous squamous cell carcinoma of the scalp. ANZ Journal of Surgery, 78(6), 449-453. [More Information]
  • Veness, M. (2008). The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. Journal of Medical Imaging and Radiation Oncology, 52(3), 278-286. [More Information]
  • Veness, M. (2008). Time to rethink TNM staging in cutaneous SCC. Lancet Oncology, 9(8), 702-703. [More Information]
  • Veness, M., Porceddu, S., Palme, C., Morgan, G. (2007). Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head and Neck. [More Information]
  • Veness, M. (2007). High-risk cutaneous squamous cell carcinoma of the head and neck. Journal of Biomedicine and Biotechnology, 2007, 80572 - 1-80572 - 6. [More Information]
  • Clark, J., Veness, M., Gilbert, R., O'Brien, C., Gullane, P. (2007). Merkel cell carcinoma of the head and neck: Is adjuvant radiotherapy necessary? Head and Neck, 29(3), 249-257. [More Information]
  • Veness, M., Harris, D. (2007). Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Journal of Medical Imaging and Radiation Oncology, 51(10), 1-12. [More Information]
  • Palme, C., MacKay, S., Kalnins, I., Veness, M. (2007). The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Current opinion in otolaryngology & head and neck surgery, 15(2), 103-106. [More Information]
  • Veness, M. (2006). Defining patients with high-risk cutaneous squamous cell carcinoma. Australasian Journal of Dermatology, 47(1), 28-33. [More Information]
  • Veness, M., Palme, C., Morgan, G. (2006). High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer, 106(11), 2389-2396. [More Information]
  • Andruchow, J., Veness, M., Morgan, G., Gao, K., Clifford, A., Shannon, K., Poulsen, M., Kenny, L., Palme, C., Gullane, P., O'Brien, C., et al (2006). Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer, 106(5). [More Information]
  • Veness, M. (2006). Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): An overview on management. The Australasian Journal of Dermatology, 47(3), 160-5. [More Information]
  • Vauterin, T., Veness, M., Morgan, G., Poulsen, M., O'Brien, C. (2006). Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head and Neck, 28(9), 785-791. [More Information]
  • Veness, M., Foroudi, F., Gebski, V., Timms, I., Sathiyaseelan, Y., Vachan, B., Tiver, K. (2006). Use of topical misoprostol to reduce radiation-induced mucositis: Results of a randomized, double-blind, placebo-controlled trial. Journal of Medical Imaging and Radiation Oncology, 50(5), 468-474. [More Information]
  • Veness, M., Gebski, V., Morgan, G. (2005). Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head and Neck, 27(3), 208-216. [More Information]
  • Veness, M., Morgan, G., Gebski, V., Sathiyaseelan, Y. (2005). Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ Journal of Surgery, 75(3), 101-105. [More Information]
  • Veness, M., Perera, L., McCourt, J., Shannon, J., Hughes, T., Morgan, G., Gebski, V. (2005). Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ Journal of Surgery, 75(5), 275-281. [More Information]
  • Veness, M. (2005). Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. Journal of Clinical Oncology, 23(28), 7235-6; author reply 7237-8. [More Information]
  • Lee, K., Veness, M., Pearl-Larson, T., Morgan, G. (2005). Role of combined modality treatment of buccal mucosa squamous cell carcinoma. Australian Dental Journal, 50(2), 108-113. [More Information]
  • Clark, J., Morgan, G., Veness, M., Dalton, C., Kalnins, I. (2005). Salvage with supracricoid partial laryngectomy after radiation failure. ANZ Journal of Surgery, 75(11), 958-962. [More Information]
  • Veness, M., Morgan, G., Palme, C., Gebski, V. (2005). Surgery and Adjuvant Radiotherapy in Patients with Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to Lymph Nodes: Combined Treatment Should be Considered Best Practice. The Laryngoscope, 115(5), 870-875. [More Information]
  • Veness, M. (2005). Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma. Journal of Medical Imaging and Radiation Oncology, 49(5), 365-376. [More Information]
  • Veness, M., Porter, G., Morgan, G. (2004). Anaplastic Thyroid Carcinoma: Dismal Outcome Despite Current Treatment Approach. ANZ Journal of Surgery, 74(7), 559-562.
  • Hyam, D., Veness, M., Morgan, G. (2004). Minor Salivary Gland Carcinoma Involving The Oral Cavity Or Oropharynx. Australian Dental Journal, 49(1), 16-Sep-19.
  • Georgiou, A., Walker, D., Collins, A., Morgan, G., Shannon, J., Veness, M. (2004). Primary Small Cell Undifferentiated (Neuroendocrine) Carcinoma Of The Maxillary Sinus. Oral microbiology and immunology, 98(5), 572-578.
  • Dinh, Q., Veness, M., Richards, S. (2004). Role Of Adjuvant Radiotherapy In Recurrent Earlobe Keloids. Australasian Journal of Dermatology, 45(3), 162-166.
  • Veness, M., Morgan, G., Sathiyaseelan, Y., Gebski, V. (2003). Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment. ANZ Journal of Surgery, 73(11), 899-904.
  • Veness, M., Rikard-Bell, G., Ward, J. (2003). Australian and New Zealand radiation oncology work practices in 2000. Journal of Medical Imaging and Radiation Oncology, 47(2), 146-151.
  • Veness, M., Palme, C., Smith, M., Vachan, B., Morgan, G., Kalnins, I. (2003). Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparatid): a better outcome with surgery and adjuvant radiotherapy. The Laryngoscope, 113(10), 1827-1833.
  • Palme, C., O'Brien, C., Veness, M., McNeil, E., Bron, L., Morgan, G. (2003). Extent of parotid disease influences outcome in patients with metastic cutaneous squamous cell carcinoma. Archives Of Otolaryngology-Head and Neck Surgery, 129(7), 750-753. [More Information]
  • Li, W., Thompson, C., O'Brien, C., McNeil, E., Scolyer, R., Cossart, Y., Veness, M., Walker, D., Morgan, G., Rose, B. (2003). Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. International Journal of Cancer, 106(4), 553-558. [More Information]
  • Veness, M., Thompson, S., Morgan, G., Shannon, J., Kench, J. (2003). Leptomeningeal carcinomatosis from squamous cell carinoma of the surpaglottic larynx. Journal of Medical Imaging and Radiation Oncology, 11, 325-330.
  • Dona, E., Veness, M., Vachan, B., Morgan, G. (2003). Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ Journal of Surgery, 73(9), 692-696.
  • Veness, M., Richards, S. (2003). Role of modern radiotherapy in treating skin cancer. Australasian Journal of Dermatology, 44(3), 159-168.
  • Babington, S., Veness, M., Vachan, B., Gebski, V., Morgan, G. (2003). Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inedequate excision? ANZ Journal of Surgery, 73(8), 621-625.
  • Hyam, D., Conway, R., Sathiyaseelan, Y., Gebski, V., Morgan, G., Walker, D., Veness, M. (2003). Tongue cancer: do patients younger than 40 do worse? Australian Dental Journal, 48(1), 50-54.
  • Veness, M., Rikard-Bell, G., Ward, J. (2003). Views of Australian and New Zealand radiation oncologists and registrars about evidence-based medicine and their access to internet based sources of evidence. Journal of Medical Imaging and Radiation Oncology, 47(4), 409-415.
  • Veness, M. (2002). Does Preoperative radiotherapy improve outcome in patients with resectable rectal cancer? Medical Journal of Australia, , 563-564.
  • Nguyen Huynh, N., Veness, M., Hunt,, M., Cachia, A. (2002). Merkel cell carcinoma and multiple cutaneous squamous cell carcinoma in a patient with pityriasis rubra pilaris. Progress In Biotechnology.
  • Veness, M., Chua, M., Morgan, G., Shakespeare, T., Hehir, A., Gebski, V., Vachan, B., Tiver, K. (2002). Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: Treatment outcome and prognostic factors following surgery and adjuvant radiotherapy. Journal of Medical Imaging and Radiation Oncology, 46(2), 174-179.
  • Nguyen Huynh, N., Veness, M. (2002). Radiotherapy for lentigo maligna. Archives of Dermatology, , 981-982.
  • Gebski, V., Veness, M., Simes, R., Shakespeare, T. (2001). Improving interpretation of clinical studies by use of confidence intervals, clinical significnce cureves, and risk analysis. The Lancet, 357, 1349-1353.
  • Shakespeare, T., Gebski, V., Veness, M., Simes, R. (2001). Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. The Lancet, 357(9265), 1349-1353.

2014

  • Howle, J., Veness, M. (2014). Outcome of Patients with Microscopic and Macroscopic Metastatic Nodal Merkel Cell Carcinoma: An Australian Experience. Dermatologic Surgery, 40(1), 46-51. [More Information]

2013

  • McLean, T., Brunner, M., Ebrahimi, A., Gao, K., Ch’ng, S., Veness, M., Clark, J. (2013). Concurrent primary and metastatic cutaneous head and neck squamous cell carcinoma: Analysis of prognostic factors. Head and Neck, 35(8), 1144-1148. [More Information]
  • Brunner, M., Veness, M., Ch'ng, S., Elliott, M., Clark, J. (2013). Distant metastases from cutaneous squamous cell carcinoma - analysis of AJCC stage IV. Head and Neck, 35(1), 72-75. [More Information]
  • Najim, M., Cross, S., Gebski, V., Palme, C., Morgan, G., Veness, M. (2013). Early-stage squamous cell carcinoma of the lip: The Australian experience and the benefits of radiotherapy in improving outcome in high-risk patients after resection. Head and Neck, 35(10), 1426-1430. [More Information]
  • Hong, A., Martin, A., Armstrong, B., Lee, C., Jones, D., Chatfield, M., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Veness, M., Veivers, D., Rose, B., et al (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24(1), 215-219. [More Information]
  • Wang, J., Palme, C., Wang, A., Morgan, G., Gebski, V., Veness, M. (2013). In patients with metastatic cutaneous head and neck squamous cell carcinoma to cervical lymph nodes, the extent of neck dissection does not influence outcome. The Journal of Laryngology and Otology, 127(Suppl. S1), S2-S7. [More Information]
  • Ebrahimi, A., Clark, J., Ahmadi, N., Palme, C., Morgan, G., Veness, M. (2013). Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases. Head and Neck, 35(8), 1138-1143. [More Information]
  • Wang, A., Palme, C., Wang, J., Morgan, G., Gebski, V., GILCHRIST, J., Veness, M. (2013). Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck. The Journal of Laryngology and Otology, 127(Suppl. S2), S39-S47. [More Information]
  • Ch'ng, S., Clark, J., Brunner, M., Palme, C., Morgan, G., Veness, M. (2013). Relevance of the primary lesion in the prognosis of metastatic cutaneous squamous cell carcinoma. Head and Neck, 35(2), 190-194. [More Information]

2012

  • Clark, J., Rumcheva, P., Veness, M. (2012). Analysis and Comparison of the 7th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System for Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Annals of Surgical Oncology, 19(13), 4252-4258. [More Information]
  • Howle, J., Hughes, T., Gebski, V., Veness, M. (2012). Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. Journal Of The American Academy Of Dermatology, 67(1), 33-40. [More Information]
  • Foote, M., Veness, M., Zarate, D., Poulsen, M. (2012). Merkel cell carcinoma: The prognostic implications of an occult primary in stage IIIB (nodal) disease. Journal Of The American Academy Of Dermatology, 67(3), 395-399. [More Information]
  • Ebrahimi, A., Clark, J., Lorincz, B., Milross, C., Veness, M. (2012). Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low-risk patient. Head and Neck, 34(3), 365-370. [More Information]
  • Wang, J., Palme, C., Morgan, G., Gebski, V., Wang, A., Veness, M. (2012). Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy. Head and Neck, 34(11), 1524-1528. [More Information]
  • Veness, M., Morgan, G., Howle, J. (2012). Recurrent Melanotic and Nonmelanotic Skin Cancer. In H. Mehanna & K. K. Ang (Eds.), Head and Neck Cancer Recurrence: Evidence-based, Multidisciplinary Management, (pp. 229-244). Stuttgart: Georg Thieme Verlag.
  • Howle, J., Veness, M. (2012). Sentinel lymph node biopsy in patients with Merkel cell carcinoma: An emerging role and the Westmead hospital experience. The Australasian Journal of Dermatology, 53(1), 26-31. [More Information]

2011

  • Palme, C., Smith, M., Veness, M. (2011). Epidemiology, Staging and Prognosis of Nonmelanoma Skin Cancer. In Randal S. Weber, Brian A. Moore (Eds.), Cutaneous Malignancy of the Head and Neck: A Multidisciplinary Approach, (pp. 101-118). San Diego, CA, USA: Plural Publishing.
  • Veness, M., Howle, J. (2011). Merkel cell carcinoma metastatic to the transverse colon: Disease free after six years - cure or just prolonged remission? Australasian Journal of Dermatology, 52(4), 295-297. [More Information]

2010

  • Poulsen, M., Round, C., Keller, J., Tripcony, L., Veness, M. (2010). Factors Influencing Relapse-Free Survival in Merkel Cell Carcinoma of the Lower Limb - A Review of 60 Cases. International Journal of Radiation: Oncology - Biology - Physics, 76(2), 393-397. [More Information]
  • Goh, A., Howle, J., Hughes, M., Veness, M. (2010). Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes. Australasian Journal of Dermatology, 51(2), 113-117. [More Information]
  • Turner, S., Morgan, G., Palme, C., Veness, M. (2010). Metastatic cutaneous squamous cell carcinoma of the external ear: a high-risk cutaneous subsite. Journal of Laryngology and Otology, 124(1), 26-31. [More Information]
  • Forest, V., Clark, J., Veness, M., Milross, C. (2010). N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer, 116(5), 1298-1304. [More Information]
  • Veness, M., Howle, J. (2010). Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases. Australasian Journal of Dermatology, 51(4), 274-278. [More Information]
  • Veness, M. (2010). Strategies to successfully publish your first manuscript. Journal of Medical Imaging and Radiation Oncology, 54(4), 395-400. [More Information]
  • Concannon, R., Larcos, G., Veness, M. (2010). The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: Results from Westmead Hospital, Sydney, Australia. Journal Of The American Academy Of Dermatology, 62(1), 76-84. [More Information]
  • Veness, M., Foote, M., Gebski, V., Poulsen, M. (2010). The Role of Radiotherapy Alone in Patients With Merkel Cell Carcinoma: Reporting the Australian Experience of 43 Patients. International Journal of Radiation: Oncology - Biology - Physics, 78(3), 703-709. [More Information]

2009

  • Oddone, N., Morgan, G., Palme, C., Perera, L., Shannon, J., Wong, E., Gebski, V., Veness, M. (2009). Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival. Cancer, 115(9), 1883-1891. [More Information]
  • Koh, C., Veness, M. (2009). Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature. Australasian Journal of Dermatology, 50(4), 249-256. [More Information]

2008

  • Veness, M., Chong, L., Tiver, K., Gebski, V. (2008). Basal cell carcinoma of the nose: An Australian and New Zealand Radiation Oncology patterns-of practice study. Journal of Medical Imaging and Radiation Oncology, 52, 382-393. [More Information]
  • Veness, M., Palme, C., Morgan, G. (2008). Merkel cell carcinoma: a review of management. Current opinion in otolaryngology & head and neck surgery, 16(2), 170-174. [More Information]
  • Howle, J., Morgan, G., Palme, C., Kalnins, I., Veness, M. (2008). Metastatic cutaneous squamous cell carcinoma of the scalp. ANZ Journal of Surgery, 78(6), 449-453. [More Information]
  • Veness, M. (2008). Radiation Therapy in Organ Transplant Recipients. In Otley C; Stasko T (Eds.), Skin Disease in Organ Transplantation, (pp. 254-261). New York, NY: Cambridge University Press.
  • Veness, M., Richards, S. (2008). Radiotherapy. In Jean L Bolognia, Joseph L Jorizzo, Ronald P Rapini (Eds.), Dermatology (2nd Edition), (pp. 2127-2138). United States: Mosby.
  • Veness, M. (2008). The important role of radiotherapy in patients with non-melanoma skin cancer and other cutaneous entities. Journal of Medical Imaging and Radiation Oncology, 52(3), 278-286. [More Information]
  • Veness, M. (2008). Time to rethink TNM staging in cutaneous SCC. Lancet Oncology, 9(8), 702-703. [More Information]

2007

  • Veness, M., Porceddu, S., Palme, C., Morgan, G. (2007). Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head and Neck. [More Information]
  • Veness, M. (2007). High-risk cutaneous squamous cell carcinoma of the head and neck. Journal of Biomedicine and Biotechnology, 2007, 80572 - 1-80572 - 6. [More Information]
  • Clark, J., Veness, M., Gilbert, R., O'Brien, C., Gullane, P. (2007). Merkel cell carcinoma of the head and neck: Is adjuvant radiotherapy necessary? Head and Neck, 29(3), 249-257. [More Information]
  • Veness, M., Harris, D. (2007). Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Journal of Medical Imaging and Radiation Oncology, 51(10), 1-12. [More Information]
  • Palme, C., MacKay, S., Kalnins, I., Veness, M. (2007). The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Current opinion in otolaryngology & head and neck surgery, 15(2), 103-106. [More Information]

2006

  • Veness, M. (2006). Defining patients with high-risk cutaneous squamous cell carcinoma. Australasian Journal of Dermatology, 47(1), 28-33. [More Information]
  • Veness, M., Palme, C., Morgan, G. (2006). High-risk cutaneous squamous cell carcinoma of the head and neck: results from 266 treated patients with metastatic lymph node disease. Cancer, 106(11), 2389-2396. [More Information]
  • Andruchow, J., Veness, M., Morgan, G., Gao, K., Clifford, A., Shannon, K., Poulsen, M., Kenny, L., Palme, C., Gullane, P., O'Brien, C., et al (2006). Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer, 106(5). [More Information]
  • Veness, M. (2006). Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): An overview on management. The Australasian Journal of Dermatology, 47(3), 160-5. [More Information]
  • Vauterin, T., Veness, M., Morgan, G., Poulsen, M., O'Brien, C. (2006). Patterns of lymph node spread of cutaneous squamous cell carcinoma of the head and neck. Head and Neck, 28(9), 785-791. [More Information]
  • Veness, M., Foroudi, F., Gebski, V., Timms, I., Sathiyaseelan, Y., Vachan, B., Tiver, K. (2006). Use of topical misoprostol to reduce radiation-induced mucositis: Results of a randomized, double-blind, placebo-controlled trial. Journal of Medical Imaging and Radiation Oncology, 50(5), 468-474. [More Information]

2005

  • Veness, M., Gebski, V., Morgan, G. (2005). Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head and Neck, 27(3), 208-216. [More Information]
  • Veness, M., Morgan, G., Gebski, V., Sathiyaseelan, Y. (2005). Anterior tongue cancer and the incidence of cervical lymph node metastases with increasing tumour thickness: should elective treatment to the neck be standard practice in all patients? ANZ Journal of Surgery, 75(3), 101-105. [More Information]
  • Veness, M., Perera, L., McCourt, J., Shannon, J., Hughes, T., Morgan, G., Gebski, V. (2005). Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ Journal of Surgery, 75(5), 275-281. [More Information]
  • Veness, M. (2005). Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. Journal of Clinical Oncology, 23(28), 7235-6; author reply 7237-8. [More Information]
  • Lee, K., Veness, M., Pearl-Larson, T., Morgan, G. (2005). Role of combined modality treatment of buccal mucosa squamous cell carcinoma. Australian Dental Journal, 50(2), 108-113. [More Information]
  • Clark, J., Morgan, G., Veness, M., Dalton, C., Kalnins, I. (2005). Salvage with supracricoid partial laryngectomy after radiation failure. ANZ Journal of Surgery, 75(11), 958-962. [More Information]
  • Veness, M., Morgan, G., Palme, C., Gebski, V. (2005). Surgery and Adjuvant Radiotherapy in Patients with Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to Lymph Nodes: Combined Treatment Should be Considered Best Practice. The Laryngoscope, 115(5), 870-875. [More Information]
  • Veness, M. (2005). Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma. Journal of Medical Imaging and Radiation Oncology, 49(5), 365-376. [More Information]

2004

  • Veness, M., Porter, G., Morgan, G. (2004). Anaplastic Thyroid Carcinoma: Dismal Outcome Despite Current Treatment Approach. ANZ Journal of Surgery, 74(7), 559-562.
  • Hyam, D., Veness, M., Morgan, G. (2004). Minor Salivary Gland Carcinoma Involving The Oral Cavity Or Oropharynx. Australian Dental Journal, 49(1), 16-Sep-19.
  • Georgiou, A., Walker, D., Collins, A., Morgan, G., Shannon, J., Veness, M. (2004). Primary Small Cell Undifferentiated (Neuroendocrine) Carcinoma Of The Maxillary Sinus. Oral microbiology and immunology, 98(5), 572-578.
  • Dinh, Q., Veness, M., Richards, S. (2004). Role Of Adjuvant Radiotherapy In Recurrent Earlobe Keloids. Australasian Journal of Dermatology, 45(3), 162-166.

2003

  • Veness, M., Morgan, G., Sathiyaseelan, Y., Gebski, V. (2003). Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment. ANZ Journal of Surgery, 73(11), 899-904.
  • Veness, M., Rikard-Bell, G., Ward, J. (2003). Australian and New Zealand radiation oncology work practices in 2000. Journal of Medical Imaging and Radiation Oncology, 47(2), 146-151.
  • Veness, M., Palme, C., Smith, M., Vachan, B., Morgan, G., Kalnins, I. (2003). Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparatid): a better outcome with surgery and adjuvant radiotherapy. The Laryngoscope, 113(10), 1827-1833.
  • Palme, C., O'Brien, C., Veness, M., McNeil, E., Bron, L., Morgan, G. (2003). Extent of parotid disease influences outcome in patients with metastic cutaneous squamous cell carcinoma. Archives Of Otolaryngology-Head and Neck Surgery, 129(7), 750-753. [More Information]
  • Li, W., Thompson, C., O'Brien, C., McNeil, E., Scolyer, R., Cossart, Y., Veness, M., Walker, D., Morgan, G., Rose, B. (2003). Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. International Journal of Cancer, 106(4), 553-558. [More Information]
  • Veness, M., Thompson, S., Morgan, G., Shannon, J., Kench, J. (2003). Leptomeningeal carcinomatosis from squamous cell carinoma of the surpaglottic larynx. Journal of Medical Imaging and Radiation Oncology, 11, 325-330.
  • Dona, E., Veness, M., Vachan, B., Morgan, G. (2003). Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ Journal of Surgery, 73(9), 692-696.
  • Veness, M., Richards, S. (2003). Role of modern radiotherapy in treating skin cancer. Australasian Journal of Dermatology, 44(3), 159-168.
  • Babington, S., Veness, M., Vachan, B., Gebski, V., Morgan, G. (2003). Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inedequate excision? ANZ Journal of Surgery, 73(8), 621-625.
  • Hyam, D., Conway, R., Sathiyaseelan, Y., Gebski, V., Morgan, G., Walker, D., Veness, M. (2003). Tongue cancer: do patients younger than 40 do worse? Australian Dental Journal, 48(1), 50-54.
  • Veness, M., Rikard-Bell, G., Ward, J. (2003). Views of Australian and New Zealand radiation oncologists and registrars about evidence-based medicine and their access to internet based sources of evidence. Journal of Medical Imaging and Radiation Oncology, 47(4), 409-415.

2002

  • Veness, M. (2002). Does Preoperative radiotherapy improve outcome in patients with resectable rectal cancer? Medical Journal of Australia, , 563-564.
  • Nguyen Huynh, N., Veness, M., Hunt,, M., Cachia, A. (2002). Merkel cell carcinoma and multiple cutaneous squamous cell carcinoma in a patient with pityriasis rubra pilaris. Progress In Biotechnology.
  • Veness, M., Chua, M., Morgan, G., Shakespeare, T., Hehir, A., Gebski, V., Vachan, B., Tiver, K. (2002). Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: Treatment outcome and prognostic factors following surgery and adjuvant radiotherapy. Journal of Medical Imaging and Radiation Oncology, 46(2), 174-179.
  • Nguyen Huynh, N., Veness, M. (2002). Radiotherapy for lentigo maligna. Archives of Dermatology, , 981-982.

2001

  • Gebski, V., Veness, M., Simes, R., Shakespeare, T. (2001). Improving interpretation of clinical studies by use of confidence intervals, clinical significnce cureves, and risk analysis. The Lancet, 357, 1349-1353.
  • Shakespeare, T., Gebski, V., Veness, M., Simes, R. (2001). Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. The Lancet, 357(9265), 1349-1353.

To update your profile click here. For support on your academic profile contact .